Quanterix Corp (QTRX): Operating Cash Flow
-$77.24M
Year ended 2025-12-31
-$80.92M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$77.24M | n/m | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | -$35.16M | n/m | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | -$18.85M | n/m | 2026-03-02, From 2023-01-01 |
| 2022-12-31 | -$48.61M | n/m | 2025-03-17, From 2022-01-01 |
| 2021-12-31 | -$47.62M | n/m | 2024-12-26, From 2021-01-01 |
| 2020-12-31 | -$23.36M | n/m | 2023-03-06, From 2020-01-01 |
| 2019-12-31 | -$26.19M | n/m | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | -$28.72M | n/m | 2021-03-05, From 2018-01-01 |
| 2017-12-31 | -$22.11M | n/m | 2020-03-13, From 2017-01-01 |
| 2016-12-31 | -$17.74M | n/a | 2019-03-18, From 2016-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Quanterix Corp (QTRX) | 2025-12-31 | -$77.24M | n/m |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | -$111.21M | n/m |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | -$4.69M | n/m |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $6.73M | +367.3% |
| 908 Devices Inc. (MASS) | 2025-12-31 | -$23.69M | n/m |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | -$31.06M | n/m |
| EyePoint, Inc. (EYPT) | 2025-12-31 | -$240.11M | n/m |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $136.05M | n/m |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | -$16.34M | n/m |
Compare QTRX, PACB, CTKB, HBIO side by side · Screen every company in Laboratory Analytical Instruments ↗